Bellevue Group AG lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 1.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 296,754 shares of the healthcare conglomerate's stock after selling 5,290 shares during the period. UnitedHealth Group makes up 2.2% of Bellevue Group AG's investment portfolio, making the stock its 12th largest holding. Bellevue Group AG's holdings in UnitedHealth Group were worth $149,873,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the business. Wealthstream Advisors Inc. increased its stake in UnitedHealth Group by 4.4% during the second quarter. Wealthstream Advisors Inc. now owns 452 shares of the healthcare conglomerate's stock worth $232,000 after purchasing an additional 19 shares during the period. CoreCap Advisors LLC increased its stake in UnitedHealth Group by 0.5% during the second quarter. CoreCap Advisors LLC now owns 4,217 shares of the healthcare conglomerate's stock worth $2,166,000 after purchasing an additional 19 shares during the period. Elgethun Capital Management increased its stake in UnitedHealth Group by 0.3% during the second quarter. Elgethun Capital Management now owns 6,577 shares of the healthcare conglomerate's stock worth $3,369,000 after purchasing an additional 19 shares during the period. Hollencrest Capital Management increased its stake in UnitedHealth Group by 0.8% during the third quarter. Hollencrest Capital Management now owns 2,337 shares of the healthcare conglomerate's stock worth $1,180,000 after purchasing an additional 19 shares during the period. Finally, Smith Salley & Associates increased its stake in shares of UnitedHealth Group by 0.7% during the third quarter. Smith Salley & Associates now owns 2,873 shares of the healthcare conglomerate's stock worth $1,451,000 after buying an additional 19 shares during the period. Institutional investors own 86.31% of the company's stock.

Analyst Ratings Changes

A number of analysts recently weighed in on UNH shares. Credit Suisse Group upped their target price on shares of UnitedHealth Group from $590.00 to $610.00 and gave the stock an "outperform" rating in a research note on Wednesday, December 7th. Royal Bank of Canada upped their target price on shares of UnitedHealth Group from $588.00 to $592.00 and gave the stock an "outperform" rating in a research note on Monday, October 17th. SVB Leerink cut their target price on shares of UnitedHealth Group from $625.00 to $618.00 and set an "outperform" rating on the stock in a research note on Monday, October 17th. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $615.00 to $617.00 and gave the company a "buy" rating in a research note on Tuesday, January 24th. Finally, Loop Capital increased their price target on shares of UnitedHealth Group from $575.00 to $590.00 in a research note on Tuesday, January 17th. Three analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and an average target price of $599.39.

UnitedHealth Group Stock Performance

UnitedHealth Group (NYSE:UNH – Get Rating) last posted its quarterly earnings data on Friday, January 13th. The healthcare conglomerate reported $5.34 earnings per share for the quarter, beating analysts' consensus estimates of $5.17 by $0.17. The firm had revenue of $82.79 billion for the quarter, compared to analyst estimates of $82.53 billion. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. UnitedHealth Group's quarterly revenue was up 12.3% on a year-over-year basis. During the same period last year, the firm posted $4.48 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 24.91 EPS for the current year.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 616 shares of the business's stock in a transaction on Friday, December 2nd. The shares were sold at an average price of $535.00, for a total transaction of $329,560.00. Following the sale, the executive vice president now directly owns 8,463 shares in the company, valued at approximately $4,527,705. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.40% of the company's stock.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Read More

• Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
• 3 Hot Stocks The Analysts Are Buying
• Hertz Global Holding Could Be A Comfortable Ride In 2023
• Two Billionaires Are Rigging the Market. Here's How to Fight Back
• Should Investors Buy or Sell the Vaccinex Patent News?
• Take-Two Interactive Or Activision Blizzard: An Obvious Choice?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Get Rating).

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.